Security key
Y95308105
Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)
CUSIP: Y95308105
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 67,784,074
- Total 13F value
- $220,297,785
- Share change
- +20,282,045
- SEC-reported price per share
- $3.25
- Number of holders
- 56
- Value change
- +$69,127,143
- Number of buys
- 21
- Number of sells
- 55
- Shares outstanding
- 188,679,245
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
56
Top holders
10
WVE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Wave Life Sciences Ltd. SEC filings
Wave Life Sciences Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP Y95308105
Recent filing periods:
Ownership snapshot
Top reported holders of WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 4.1%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 4.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
4.1%
M28 Capital Management LP
3.1%
MAVERICK CAPITAL LTD
3%
Bellevue Group AG
2.4%
PRIMECAP MANAGEMENT CO/CA/
2.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
4.1%
|
$15,550,000
7,775,207 shares
|
— | 31 Mar 2022 |
| M28 Capital Management LP |
13F
Company
|
3.1%
|
$11,700,000
5,850,000 shares
|
— | 31 Mar 2022 |
| MAVERICK CAPITAL LTD |
13F
Company
|
3%
|
$11,187,000
5,593,389 shares
|
— | 31 Mar 2022 |
| Bellevue Group AG |
13F
Company
|
2.4%
|
$9,126,000
4,562,858 shares
|
— | 31 Mar 2022 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
2.4%
|
$9,123,000
4,561,275 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
1.6%
|
$5,876,000
2,937,786 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
56
Shares
67,784,074
Rows available
56
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
77
Q2 2022 holders
56
Holder diff
-21
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend